- Home
- HIMS
as 11-21-2024 10:35am EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 4.1B | IPO Year: | N/A |
| Target Price: | $21.54 | AVG Volume (30 days): | 21.7M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.67 - $30.44 | Next Earning Date: | 11-04-2024 |
| Revenue: | $1,241,994,000 | Revenue Growth: | 56.70% |
| Revenue Growth (this year): | 69.84% | Revenue Growth (next year): | 38.42% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Chi Michael | HIMS | Chief Commercial Officer | Nov 19 '24 | Sell | $22.00 | 7,500 | $165,000.00 | 183,980 | |
| Baird Melissa | HIMS | Chief Operating Officer | Nov 18 '24 | Sell | $20.92 | 58,750 | $1,236,363.80 | 658,690 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Nov 13 '24 | Sell | $28.98 | 142,886 | $4,276,608.76 | 252,684 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Nov 12 '24 | Sell | $26.46 | 2,338 | $61,863.48 | 167,597 | |
| Carroll Patrick Harrison | HIMS | Chief Medical Officer | Nov 11 '24 | Sell | $28.24 | 4,707 | $132,925.68 | 192,234 | |
| Chi Michael | HIMS | Chief Commercial Officer | Nov 11 '24 | Sell | $24.77 | 7,259 | $179,805.43 | 183,980 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Nov 5 '24 | Sell | $21.00 | 333,332 | $6,921,163.62 | 519,004 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Oct 29 '24 | Sell | $23.16 | 2,339 | $54,171.24 | 167,597 | |
| Chi Michael | HIMS | Chief Commercial Officer | Oct 25 '24 | Sell | $22.00 | 17,304 | $380,688.00 | 183,980 | |
| Chi Michael | HIMS | Chief Commercial Officer | Oct 21 '24 | Sell | $22.20 | 7,500 | $166,500.00 | 183,980 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
Investor's Business Daily
21 hours ago
Guardant Health Stock Sees RS Rating Jump To 83
Business Wire
3 days ago
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
Investor's Business Daily
6 days ago
Netflix, Five Other Gems Soar Into Profit Zones In Hot November Rally
The Wall Street Journal
7 days ago
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
Yahoo Finance
8 days ago
Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision
Business Wire
8 days ago
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
Argus Research
9 days ago
HIMS: Raising target price to $28.00
Simply Wall St.
9 days ago
Hims & Hers Health's (NYSE:HIMS) Strong Earnings Are Of Good Quality
Compare HIMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.